Sudeep Pharma Ltd
Fri 10/07/2026,15:56:2 | NSE : SUDEEPPHRM
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 807.15
Previous Close
₹ 802.30
Volume
170046
Mkt Cap ( Rs. Cr)
₹9309.79
High
₹ 834.50
Low
₹ 807.15
52 Week High
₹ 894.45
52 Week Low
₹ 524.05
Book Value Per Share
₹ 78.21
Dividend Yield
0.18
Face Value
₹ 1.00
What’s Your Call?
Collective community sentiment on Sudeep Pharma Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
824.25
149
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
149
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Sudeep Pharma Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Sudeep Pharma - Intimation Of Record Date For Payment Of Final Dividend On Equity Shares For The Financial Year 2025-26
-
Sudeep Pharma - Letter To Shareholders In Relation To Integrated Annual Report Of The Company For The Financial Year 2025-26
-
Sudeep Pharma - Reg. 34 (1) Annual Report.
-
Sudeep Pharma - Notice Of 37Th Annual General Meeting
-
Sudeep Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Sudeep Pharma - Outcome of Board Meeting
-
Sudeep Pharma - Announcement under Regulation 30 (LODR)-Change in Management
-
Sudeep Pharma - Appointment
-
Sudeep Pharma - Board Meeting Outcome for Appointment Of Mr. Milin Mehta As An Additional Director (Non-Executive & Non-Indep
-
Sudeep Pharma - Trading Window
-
Sudeep Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
-
Sudeep Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Sudeep Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
-
Sudeep Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Sudeep Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
-
Sudeep Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Sudeep Pharma - Copy of Newspaper Publication
-
Sudeep Pharma - Investor Presentation
-
Sudeep Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Sudeep Pharma Q4 net profit down 22.24% at Rs 25.77 cr
-
Sudeep Pharma - Dividend
-
Sudeep Pharma - Outcome of Board Meeting
-
Sudeep Pharma - Outcome of Board Meeting
-
Sudeep Pharma - Announcement under Regulation 30 (LODR)-Dividend Updates
-
Sudeep Pharma - Submission Of Financial Results For The Year Ended 31St March 2026
-
Sudeep Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On 21St May 2026
-
Sudeep Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
-
Sudeep Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Sudeep Pharma - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financials For The Fourth Quarte
Key fundamentals
Evaluate the intrinsic value of Sudeep Pharma Ltd stockÂ
| Name | March-26 | March-25 | March-24 | ||
|---|---|---|---|---|---|
| Assets | 910.9401 | 548.6406 | 392.6459 | ||
| Liabilities | 910.9401 | 548.6406 | 392.6459 | ||
| Equity | 11.2949 | 9.7228 | 1.4091 | ||
| Gross Profit | 119.7688 | 131.9581 | 132.2239 | ||
| Net Profit | 107.5807 | 95.7477 | 98.0786 | ||
| Cash From Operating Activities | 96.0152 | 59.1509 | 59.0487 | ||
| NPM(%) | 31.78 | 26.84 | 28.53 | ||
| Revenue | 338.5054 | 356.7318 | 343.759 | ||
| Expenses | 218.7366 | 224.7737 | 211.5351 | ||
| ROE(%) | 12.17 | 10.83 | 11.1 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 1.5 | 150 | 0.18 | 668.2 |
Peers
Other companies within the same industry or sector that are comparable to Sudeep Pharma Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 701.25 | 0.68 | 0.00 | 469.93 | -26.19 | 0.71 |
| Lotus Eye Hospital and Institute Ltd | 118.28 | -2.34 | 3942.67 | 1712.37 | 0.39 | 0.00 |
| Vaishali Pharma Ltd | 7.56 | 5.00 | 25.20 | 10742.25 | 15.42 | 0.00 |
| Astec Lifesciences Ltd | 689.20 | 0.37 | 0.00 | 1834.71 | -363.14 | 0.00 |
Company Info
The Company was incorporated as `Sudeep Pharma Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated December 21, 1989, issued by the Registrar of Companies, Gujarat at Ahmedabad. Thereafter, the Company was converted into a public limited company and the name of our Company was accordingly changed to `Sudeep Pharma Limited' pursuant to fresh certificate of incorporation dated April 5, 1995, issued by the Assistant Registrar of Companies, Gujarat at Dadra & Nagar Haveli. The Company was subsequently converted back to a private limited company under the Companies Act, 2013 vide a fresh certificate of incorporation dated October 1, 2014 issued by the Assistant Registrar of Companies, Gujarat at Ahmedabad, and the name of the Company was accordingly changed from `Sudeep Pharma Limited' to `Sudeep Pharma Private Limited'. Further, pursuant to the special resolution passed by our shareholders dated August 17, 2024 and the fresh certificate of incorporation dated October 21, 2024 issued by the Registrar of Companies, Central Processing Centre, The Company was converted into a public limited company and consequently, the name of the Company was changed to `Sudeep Pharma Limited'.Major Events and Milestones:1989- Incorporation of the Company2017- The Company obtained USFDA certification for mineral based ingredients2020- Incorporation of the Subsidiary, Sudeep Pharma USA Inc.2021- Incorporation of the Subsidiary, Sudeep Nutrition Private Limited2022- The Company obtained written confirmation certification for sale of calcium carbonate as an active pharmaceutical ingredient.2023- Incorporation of the Subsidiary, Sudeep Pharma B.V.2024- Incorporation of our Subsidiary, Sudeep Advanced Materials Private Limited- The Subsidiary, Sudeep Nutrition Private Limited, introduced liposomal encapsulation of nutrients for enhanced absorption2025- Acquisition of the Step-down Subsidiary, Nutrition Supplies and Services (Ireland) Limited
The Company was incorporated as `Sudeep Pharma Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated December 21, 1989, issued by the Registrar of Companies, Gujarat at Ahmedabad. Thereafter, the Company was converted into a public limited company and the name of our Company was accordingly changed to `Sudeep Pharma Limited' pursuant to fresh certificate of incorporation dated April 5, 1995, issued by the Assistant Registrar of Companies, Gujarat at Dadra & Nagar Haveli. The Company was subsequently converted back to a private limited company under the Companies Act, 2013 vide a fresh certificate of incorporation dated October 1, 2014 issued by the Assistant Registrar of Companies, Gujarat at Ahmedabad, and the name of the Company was accordingly changed from `Sudeep Pharma Limited' to `Sudeep Pharma Private Limited'. Further, pursuant to the special resolution passed by our shareholders dated August 17, 2024 and the fresh certificate of incorporation dated October 21, 2024 issued by the Registrar of Companies, Central Processing Centre, The Company was converted into a public limited company and consequently, the name of the Company was changed to `Sudeep Pharma Limited'.Major Events and Milestones:1989- Incorporation of the Company2017- The Company obtained USFDA certification for mineral based ingredients2020- Incorporation of the Subsidiary, Sudeep Pharma USA Inc.2021- Incorporation of the Subsidiary, Sudeep Nutrition Private Limited2022- The Company obtained written confirmation certification for sale of calcium carbonate as an active pharmaceutical ingredient.2023- Incorporation of the Subsidiary, Sudeep Pharma B.V.2024- Incorporation of our Subsidiary, Sudeep Advanced Materials Private Limited- The Subsidiary, Sudeep Nutrition Private Limited, introduced liposomal encapsulation of nutrients for enhanced absorption2025- Acquisition of the Step-down Subsidiary, Nutrition Supplies and Services (Ireland) Limited
Read More
Parent Organisation
Sudeep Pharma Ltd.
Founded
21/12/1989
Managing Director
Mr.Sujit Jaysukh Bhayani
NSE Symbol
SUDEEPPHRMEQ
FAQ
The current price of Sudeep Pharma Ltd is ₹ 824.25.
The 52-week high for Sudeep Pharma Ltd is ₹ 834.50 and the 52-week low is ₹ 807.15.
The market capitalization of Sudeep Pharma Ltd is currently ₹ 9309.79. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Sudeep Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Sudeep Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sudeep Pharma Ltd shares.
The CEO of Sudeep Pharma Ltd is Mr.Sujit Jaysukh Bhayani, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
